This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Biogen’s fair value estimate has inched up from $170.03 to $172.34, reflecting a slight improvement in the company’s intrinsic valuation. This update comes as analysts weigh recent progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback